Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Colgin Mark — AspenBio Pharma, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Colgin Mark

Colgin Mark

Chief Scientific Officer at AspenBio Pharma, Inc. · on record since Mar 2, 2009

Insider trading activity of Colgin Mark

Transactions on record: 2; since Jan 21, 2010

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 7, 2011

Figures computed from official regulatory filings — methodology.

Companies where Colgin Mark has traded

AspenBio Pharma, Inc.2 tx · Jan 7, 2011

Track record of Colgin Mark

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Colgin Mark

Co-insiders of Colgin Mark

1837 Partners L.P.AspenBio Pharma, Inc.
1837 Partners Ltd.AspenBio Pharma, Inc.
1837 Partners QP L.P.AspenBio Pharma, Inc.
1837 RMB Managers L.L.C.AspenBio Pharma, Inc.
Beeghley Michael MartinAspenBio Pharma, Inc.
Bennett Gregory LAspenBio Pharma, Inc.
Brooks Megan M.AspenBio Pharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

CASPARI ROBERT FREDERICKAspenBio Pharma, Inc.

Chang Robby Sai KitAspenBio Pharma, Inc.

Cho HannahAspenBio Pharma, Inc.

Chung JasonAspenBio Pharma, Inc.

Dai MikeAspenBio Pharma, Inc.

D'Ambrosio Lance VarroAspenBio Pharma, Inc.

Donnelly Richard GAspenBio Pharma, Inc.

Ensey ChristopherAspenBio Pharma, Inc.

Evans Susan AAspenBio Pharma, Inc.

FAULKNER DARYLAspenBio Pharma, Inc.

Gibbs JonathanAspenBio Pharma, Inc.

Harris Chad EverettAspenBio Pharma, Inc.

HEPLER DOUGLAS IAspenBio Pharma, Inc.

Honig Barry CAspenBio Pharma, Inc.

Howell Stephen Mitchell Jr.AspenBio Pharma, Inc.

Hurd Donald RAspenBio Pharma, Inc.

HURST ROGERAspenBio Pharma, Inc.

Jackman William RichardAspenBio Pharma, Inc.

KAPLAN ANDREW JAspenBio Pharma, Inc.

LANDMANN CATHYAspenBio Pharma, Inc.

LANDON JOHN HAspenBio Pharma, Inc.

Les JasonAspenBio Pharma, Inc.

Leverton JaimeAspenBio Pharma, Inc.

Lundy SteveAspenBio Pharma, Inc.

Mancini RemoAspenBio Pharma, Inc.

Marleau HubertAspenBio Pharma, Inc.

MCGONEGAL JEFFREYAspenBio Pharma, Inc.

Merson Michael RAspenBio Pharma, Inc.

Miller ErikAspenBio Pharma, Inc.

Mouton DouglasAspenBio Pharma, Inc.

Northern Data AGAspenBio Pharma, Inc.

O'Rourke John R. IIIAspenBio Pharma, Inc.

Peierls Brian EAspenBio Pharma, Inc.

PEIERLS E JEFFREYAspenBio Pharma, Inc.

Peierls Foundation, Inc.AspenBio Pharma, Inc.

PUSEY GREGORYAspenBio Pharma, Inc.

RATAIN MARK JAspenBio Pharma, Inc.

Roaring Fork Capital SBIC, L.P.AspenBio Pharma, Inc.

Robertsen Daniel StefanAspenBio Pharma, Inc.

ROUTH MICHAEL WAspenBio Pharma, Inc.

SCHOETTLER GAILAspenBio Pharma, Inc.

So EricAspenBio Pharma, Inc.

Talon Opportunity Managers, L.L.C.AspenBio Pharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
AspenBio Pharma, Inc.	Jan 7, 2011	AwardD	10,000	0.00 USD	$0	SEC
AspenBio Pharma, Inc.	Jan 21, 2010	AwardD	50,000	0.00	$0	SEC